Balaxi Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	394	622.91	282.17	71.93	16.69
Short-Term Investments	-	13.04	2.81	2.48	1.84	-
Cash & Short-Term Investments	388.49	407.03	625.72	284.65	73.77	16.69
Cash Growth	-36.17%	-34.95%	119.82%	285.85%	342.01%	-58.28%
Accounts Receivable	-	1,108	557.05	522.82	275.59	767.59
Other Receivables	-	18.66	12.95	10.73	18.48	6.05
Receivables	-	1,158	589.01	550.02	311.84	774.12
Inventory	-	784.81	821.68	1,050	987.04	136.18
Prepaid Expenses	-	22.14	20.17	37.77	31.22	7.19
Other Current Assets	-	55.99	45.14	12.44	6.16	3.53
Total Current Assets	-	2,428	2,102	1,935	1,410	937.71
Property, Plant & Equipment	-	363.11	170.87	190.16	60.27	11.67
Long-Term Investments	-	-	-	-	44.7	34.16
Goodwill	-	267.45	261	252.24	233.02	12.79
Other Long-Term Assets	-	45.21	49.84	19.19	16.69	0.46
Total Assets	-	3,103	2,583	2,397	1,765	996.8
Accounts Payable	-	161.78	290.38	345.19	491.15	220.58
Accrued Expenses	-	46.02	46.1	28.02	32.6	28.88
Short-Term Debt	-	303.8	176.61	107.51	36.38	36.59
Current Income Taxes Payable	-	33.67	28.83	50.57	72.52	60.12
Current Unearned Revenue	-	-	-	-	-	0.63
Other Current Liabilities	-	0.05	0.05	0.05	0.03	0.13
Total Current Liabilities	-	545.32	541.98	531.33	632.68	346.93
Long-Term Debt	-	212.45	-	8.7	-	-
Long-Term Leases	-	18.01	17.43	16.86	-	-
Long-Term Deferred Tax Liabilities	-	9	9.95	11.01	0.39	0.07
Other Long-Term Liabilities	-	1.29	0.43	-	-	-
Total Liabilities	-	786.06	569.79	567.89	633.06	347
Common Stock	-	110.42	108.98	101.81	100	100
Additional Paid-In Capital	-	565.8	508.44	192.46	112.53	112.53
Retained Earnings	-	1,641	1,358	1,432	919.11	437.27
Comprehensive Income & Other	-	-	37.73	102.97	-	-
Shareholders' Equity	2,380	2,317	2,014	1,829	1,132	649.8
Total Liabilities & Equity	-	3,103	2,583	2,397	1,765	996.8
Total Debt	565.23	534.25	194.04	133.07	36.38	36.59
Net Cash (Debt)	-176.74	-127.22	431.68	151.58	37.39	-19.9
Net Cash Growth	-	-	184.78%	305.40%	-	-
Net Cash Per Share	-3.27	-2.30	8.39	2.99	0.75	-0.40
Filing Date Shares Outstanding	50.83	55.21	50.91	50.91	50	50
Total Common Shares Outstanding	50.83	55.21	50.91	50.91	50	50
Working Capital	-	1,882	1,560	1,404	777.36	590.78
Book Value Per Share	45.56	41.98	39.56	35.92	22.63	13.00
Tangible Book Value	2,070	2,050	1,753	1,577	898.62	637.01
Tangible Book Value Per Share	39.61	37.13	34.43	30.97	17.97	12.74

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.